Figure 1. Design of the Trial.

Three patients withdrew during follow-up because they moved to other regions: the two patients in the conventional-therapy group withdrew after 0.4 and 4.7 years of follow-up, respectively, and the patient in the intensive-therapy group withdrew after 3.2 years. CVD denotes cardiovascular disease.